Lexicon Pharmaceuticals Inc (LXRX)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -88.85M | -31.61M | -69.73M | -111.35M | -161.9M | -55.13M | -103.67M | -157.29M |
Cash from Investing Activities | -71.08M | 12.09M | -62.52M | -101.84M | -49.94M | -110.22M | -122.55M | -69.08M |
Cash from Financing Activities | 142.21M | -824k | 188.17M | 187.96M | 187.96M | 239.38M | 239.37M | 238.45M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -175.63M | -185.39M | -148.61M | 113.81M | -142.97M | -87.02M | -88.85M | -161.9M |
Cash from Investing Activities | 18.25M | 50.52M | 169.58M | -155.86M | 380.76M | 2.11M | -71.08M | -49.94M |
Cash from Financing Activities | 987k | 149.93M | -2.24M | -2.23M | -147.64M | 22.71M | 142.21M | 187.96M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.